BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19639227)

  • 1. Role of angiotensin II type 1 receptor in cerebral aneurysm formation in rats.
    Aoki T; Nishimura M; Kataoka H; Ishibashi R; Miyake T; Takagi Y; Morishita R; Hashimoto N
    Int J Mol Med; 2009 Sep; 24(3):353-9. PubMed ID: 19639227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan.
    Fujiwara Y; Shiraya S; Miyake T; Yamakawa S; Aoki M; Makino H; Nishimura M; Morishita R
    Int J Mol Med; 2008 Dec; 22(6):703-8. PubMed ID: 19020766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats.
    Aoki T; Kataoka H; Ishibashi R; Nozaki K; Hashimoto N
    Stroke; 2008 Apr; 39(4):1276-85. PubMed ID: 18309148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis.
    Mahmood J; Khan F; Okada S; Kumagai N; Morioka T; Oite T
    Kidney Int; 2006 Nov; 70(9):1591-8. PubMed ID: 16985512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury.
    Wu L; Iwai M; Nakagami H; Li Z; Chen R; Suzuki J; Akishita M; de Gasparo M; Horiuchi M
    Circulation; 2001 Nov; 104(22):2716-21. PubMed ID: 11723025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine inhibits the progression of an experimentally induced cerebral aneurysm in rats with associated down-regulation of NF-kappa B transcriptional activity.
    Aoki T; Kataoka H; Ishibashi R; Nozaki K; Hashimoto N
    Curr Neurovasc Res; 2008 Feb; 5(1):37-45. PubMed ID: 18289020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARγ activation.
    Chen HY; Xu Z; Chen LF; Wang W; Fang Q; Yan XW
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):570-5. PubMed ID: 22392065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes.
    Tsuchiya K; Yoshimoto T; Hirono Y; Tateno T; Sugiyama T; Hirata Y
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E771-8. PubMed ID: 16705055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity.
    Hasan AU; Ohmori K; Hashimoto T; Kamitori K; Yamaguchi F; Ishihara Y; Ishihara N; Noma T; Tokuda M; Kohno M
    Hypertens Res; 2014 Jul; 37(7):621-8. PubMed ID: 24599011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On angiotensin II receptor distribution after myocardial infarction in dogs].
    Qu XF; Li JJ; Xi Y; Shen JX; Xiu CH; Yue L; Wang GZ; Huang YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):358-62. PubMed ID: 19791474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of endothelial tight junction proteins is related to cerebral aneurysm formation in rats.
    Tada Y; Yagi K; Kitazato KT; Tamura T; Kinouchi T; Shimada K; Matsushita N; Nakajima N; Satomi J; Kageji T; Nagahiro S
    J Hypertens; 2010 Sep; 28(9):1883-91. PubMed ID: 20577123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidapril inhibits cerebral aneurysm formation in an angiotensin-converting enzyme-independent and matrix metalloproteinase-9-dependent manner.
    Ishibashi R; Aoki T; Nishimura M; Miyamoto S
    Neurosurgery; 2012 Mar; 70(3):722-30. PubMed ID: 21937941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
    Chen K; Mehta JL; Li D; Joseph L; Joseph J
    Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II is a crucial factor in retinal aneurysm formation.
    Chen H; Zhao XY; Chen YX; Deng TT
    Exp Eye Res; 2021 Dec; 213():108810. PubMed ID: 34757002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation.
    Siragy HM; Xue C; Abadir P; Carey RM
    Hypertension; 2005 Jan; 45(1):133-7. PubMed ID: 15534073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
    Müller DN; Mervaala EM; Dechend R; Fiebeler A; Park JK; Schmidt F; Theuer J; Breu V; Mackman N; Luther T; Schneider W; Gulba D; Ganten D; Haller H; Luft FC
    Am J Pathol; 2000 Jul; 157(1):111-22. PubMed ID: 10880382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
    Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
    Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients.
    Yang HY; Kao PF; Chen TH; Tomlinson B; Ko WC; Chan P
    J Clin Pharmacol; 2007 Mar; 47(3):397-403. PubMed ID: 17322151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.